| Name | Title | Contact Details |
|---|
HR Pharmaceuticals, Inc. is a Delaware registered corporation headquartered in York, Pennsylvania. Owner of the two (2) legacy brands of surgical lubricant: Surgilube & HR Lubricating Jelly; the standard in the medical community for over 85 years. Since the inception of HR Pharma in 2008 we have developed a reputation of quality, safety and value; these same principles date back to 1931 of producing quality products that benefit mankind. With Manufacturing Integrity and 100% compliance to ISO 9001:2008, ISO 13485:2003, cGMP requirements and the Orthodox Union, HR® creates value for our customers by continuously delivering safe and effective medical devices, pharmaceuticals & other consumer products. HR is one of central PA`s fastest growing companies. We have increased our product offering by 2000% since 2011, and are continuing this growth into 2016. We take pride in offering quality, affordable, and American made products and will continue to develop new products based on this philosophy. We emphasize a vibrant and non-bureaucratic culture which we believe has formed our meaningful and productive team.
About Medical is a Saint Paul, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
MediBeacon was formed in 2012 specifically to acquire the optical diagnostic program from Mallinckrodt, the Pharmaceuticals business of Covidien. MediBeacon mission is to commercialize biocompatible optical diagnostic agents for physiological monitoring, surgical guidance, and imaging of pathological disease in the human population. Several product concepts in these arenas are contained in the MediBeacon Intellectual Property (IP) portfolio.
Micropulse, Inc., located 30 miles east of the Orthopaedic Capital of the World, has been serving the Medical Device Industry as a manufacturer of orthopaedic instruments and implants since 1988. Although Micropulse was founded as a precision tooling
Clarity Medical Systems, Inc. is a medical device company that develops, manufactures and markets integrated optical systems and services to enhance the clinician`s ability to diagnose, manage, and treat eye disorders. These patented devices combine innovative 21st century optical, electronic and information technologies that change the very nature of eye healthcare. The Company`s initial product line has improved the standard of eye healthcare for pediatrics and is sold to leading Neonatal Intensive Care Units on a global basis. The Company`s first product line, the RetCam, is a major achievement in providing miniaturized, integrated, wide-field imaging for management of eye disorders in infants. The RetCam has revolutionized disease management for pediatric eye disorders and has been the enabling tool for several international clinical trials. Customers include: Stanford University, Bascom-Palmer Eye Institute, UCLA Jules Stein Eye Institute, Toronto Hospital for Sick Kids, Cleveland Clinic, USC Children`s Hospital, and Wills Eye Institute.